| Product Code: ETC11262156 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, the Netherlands continues to be a key importer of adeno-associated virus CDMO shipments, with top exporting countries including Belgium, Hungary, USA, Japan, and Sweden. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 stands at a steady 3.85%. However, there was a notable decline in growth rate from 2023 to 2024 at -42.93%, indicating a potential shift in market dynamics or factors influencing the import of these shipments in the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Adeno Associated Virus CDMO Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Adeno Associated Virus CDMO Market - Industry Life Cycle |
3.4 Netherlands Adeno Associated Virus CDMO Market - Porter's Five Forces |
3.5 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Netherlands Adeno Associated Virus CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for gene therapy products in the Netherlands |
4.2.2 Growing prevalence of genetic disorders driving the need for gene therapy solutions |
4.2.3 Advancements in biotechnology and genetic engineering leading to more applications of adeno-associated virus (AAV) in gene therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for gene therapy products |
4.3.2 Limited availability of skilled professionals in the gene therapy and AAV manufacturing field |
4.3.3 High costs associated with AAV manufacturing and gene therapy development |
5 Netherlands Adeno Associated Virus CDMO Market Trends |
6 Netherlands Adeno Associated Virus CDMO Market, By Types |
6.1 Netherlands Adeno Associated Virus CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.4 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.5 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.6 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Netherlands Adeno Associated Virus CDMO Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.2.3 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.2.4 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Netherlands Adeno Associated Virus CDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.3.3 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.4 Netherlands Adeno Associated Virus CDMO Market Revenues & Volume, By Others, 2021 - 2031F |
7 Netherlands Adeno Associated Virus CDMO Market Import-Export Trade Statistics |
7.1 Netherlands Adeno Associated Virus CDMO Market Export to Major Countries |
7.2 Netherlands Adeno Associated Virus CDMO Market Imports from Major Countries |
8 Netherlands Adeno Associated Virus CDMO Market Key Performance Indicators |
8.1 Number of new gene therapy product launches utilizing AAV technology in the Netherlands |
8.2 Research and development investments in gene therapy and AAV manufacturing facilities |
8.3 Number of partnerships and collaborations between pharmaceutical companies and AAV CDMOs in the Netherlands |
9 Netherlands Adeno Associated Virus CDMO Market - Opportunity Assessment |
9.1 Netherlands Adeno Associated Virus CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Netherlands Adeno Associated Virus CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Adeno Associated Virus CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Adeno Associated Virus CDMO Market - Competitive Landscape |
10.1 Netherlands Adeno Associated Virus CDMO Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Adeno Associated Virus CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here